Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
- Resource Type
- Article
- Source
- The Lancet; May 2020, Vol. 395 Issue: 10237 p1613-1626, 14p
- Subject
- Language
- ISSN
- 01406736; 1474547X